Zenagamtide

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

ObesityOverweight

Phase 3

AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight

Not yet recruitingNCT07668401

Novo Nordisk A/SObesity, Overweight

Start: 2027-01-07End: 2029-01-11Target: 400Updated: 2026-06-25

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Not yet recruitingNCT07668414

Novo Nordisk A/SObesity, Overweight

Start: 2026-09-22End: 2028-10-10Target: 650Updated: 2026-06-25